Delivery Order SPE2DR25D1017-SPE2DR26F9DFC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Lenvima 18 mg daily dose in a 90-count package. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 4, 2026, to be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,773.72 for Lenvima 14 mg daily dose (60-count supply) on December 23, 2025, with an ultimate completion date of January 15, 2026. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $10,773.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Lenvima 18 mg daily dose medication in 90-count units. The contract, which is not set-aside and carries an ultimate completion date of January 27, 2026, represents a competitively awarded purchase under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Lenvima 18 mg daily dose in a 90-day supply quantity. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lenvima 10 mg daily dose tablets in a 30-count quantity, with a ceiling value of $10,223.24 and a firm fixed price structure. The contract carries an ultimate completion date of November 18, 2025, and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $10,773.72 to AmerisourceBergen Drug Corp for Lenvima 18 mg daily dose, a 90-day supply. The contract is a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs...
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of LENVIMA 14 mg daily dose tablets in a 60-count package. The contract is a firm fixed price delivery order with an ultimate completion date of January 21, 2026, and represents a non-competitive, competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 20, 2025, for the supply of Lenvima 10 mg daily dose tablets (30-count units) with a ceiling value of $10,773.72. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $21,547.44 delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Lenvima (lesinurad) 20 mg daily dose in a 60-count package. The contract, which carries a completion date of February 4, 2026, is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,223.24 on August 18, 2025, for the supply of LENVIMA 10 mg daily dose tablets (30-count) under a firm fixed-price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by September 9, 2025. The delivery order represents a child contract under AmerisourceBergen's...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9DFCDelivery Order
On January 14, 2026, the Defense Logistics Agency awarded a $43,094.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Lenvima 4 mg capsules (30-count units). This is a non-set-aside competitive award with an ultimate completion date of February 5, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. (doing business as AmerisourceBergen) holding the underlying Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical valued at $999,999,999.00 through December 2026. Lenvima is a prescription oncology medication used in cancer treatment, supporting the military healthcare supply chain's need for specialized pharmaceuticals. This delivery order is issued under the larger DLA pharmaceutical supply vehicle, which enables the contractor to furnish a comprehensive range of medications and medical supplies to military treatment facilities, the Defense Health Agency, and other federal healthcare systems worldwide. AmerisourceBergen's demonstrated capability in managing large-scale federal pharmaceutical procurement, combined with its competitive award history across multiple therapeutic domains, positions it as a critical vendor for federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.1k | 1/13/26 |